The proteomic identification of upregulated EphA2 and EPH-ephrin pathway components in PAK4KO cells provides a mechanistic link, as EphA2 promotes VM in aggressive cancers by enabling tumour cell plasticity and vessel-like structure formation [64,65]. The gene discussed is EPHA2; the disease is cancer.